过去一年中添加的文章，按日期排序
… OF INTRAVESICAL FC-OPTIMIZED ANTI-CD40 AGONIST ANTIBODY 2141-V11 FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO …
BH Bochner, M Alam, JC Osorio, JL Wong… - The Journal of …, 2024 - auajournals.org
24 天前 - … radical cystectomy (NCT05126472) (N=25). Following complete transurethral
resection, … Intravesical 2141-V11 is well tolerated up to 70 mg with minimal local side effects and …
resection, … Intravesical 2141-V11 is well tolerated up to 70 mg with minimal local side effects and …
Neoadjuvant Enfortumab Vedotin Associated With Substantial Antitumor Activity in Muscle-Invasive Bladder Cancer.
C Flaherty - Oncology Nursing News, 2023 - go.gale.com
303 天前 - … achieved a pathologic complete response (pCR; n = 8). Of … and undergo transurethral
resection of the bladder tumor up … Standard-of-care (SOC) radical cystectomy and pelvic …
resection of the bladder tumor up … Standard-of-care (SOC) radical cystectomy and pelvic …